Alexander I. Spira

机构：Inova Fairfax Hospital, Virginia Cancer Specialists · ORCID：0000-0003-1303-0447

发表论文 952 篇 · 总被引 30312 次 · h-index 68

代表论文

• Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC (2025 · Journal of Thoracic Oncology · 被引 7)
• Amivantamab Plus Lazertinib in Atypical EGFR -Mutated Advanced Non–Small Cell Lung Cancer: Results From CHRYSALIS-2 (2025 · Journal of Clinical Oncology · 被引 5)
• Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non–Small Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations (2025 · Cancer Research · 被引 5)
• A phase 1/2, open-label study of oral S241656 (BDTX-4933) as monotherapy and in combination with other anti-cancer therapies in patients with KRAS, BRAF and other selected RAS/MAPK mutation positive malignancies. (2026 · Journal of Clinical Oncology · 被引 1)
• Dose Escalation Trial of the Combination of Osimertinib and Quaratusugene Ozeplasmid Gene Therapy in Patients with Advanced NSCLC (2025 · Clinical Lung Cancer · 被引 1)
• Table S2 from Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors (2026)